LONG-TERM CARDIOVASCULAR AND RENAL OUTCOMES OF SGLT2 INHIBITORS IN NON-DIABETIC CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS. Frontier in Medical and Health Research, [S. l.], v. 4, n. 3, p. 3196–3217, 2026. Disponível em: https://fmhr.net/index.php/fmhr/article/view/3537.. Acesso em: 8 nov. 2026.